PAVmed Inc (PAVM) — Strategic Asset Allocation Index
PAVmed Inc (PAVM) has a Strategic Asset Allocation Index of 122.6% as of September 2025. Strategic assets (PP&E of $- plus long-term investments of $31.61 Million) total $31.61 Million, measured against net assets of $25.79 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check PAVmed Inc (PAVM) asset resilience to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
PAVmed Inc Strategic Asset Allocation Index (2021–2022)
This chart shows how PAVmed Inc's Strategic Asset Allocation Index has evolved across 2 annual periods from 2021 to 2022. As of September 2025, the index stands at 122.6%, representing strategic assets of $31.61 Million against net assets of $25.79 Million USD. See financial agility of PAVmed Inc to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for PAVmed Inc (2021–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for PAVmed Inc from 2021 to 2022, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see PAVmed Inc stock valuation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 50.2% | $5.49 Million | $5.49 Million | $- | $10.93 Million | ▲ +48.2 pp |
| 2021 | 2.0% | $1.58 Million | $1.58 Million | $- | $79.42 Million | — |